LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host

EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and

Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June 9, 2025

Climate capitalism won’t save us Channel

… drive up demand for American agricultural products. MANILA, Philippines – The

IHG Hotels & Resorts (IHG), one of the world’s leading hotel companies, has accelerated its growth in Vietnam by signing

As Frank Lloyd Wright’s birthday on the 8th of June approaches, Illinois is stepping into the spotlight as the premier

New research from Travelzoo — the club for travel enthusiasts that reaches 30 million travellers with outstanding travel, entertainment and

Escape the extreme heat this summer and immerse yourself in the authentic beauty of the Algarve by visiting lesser known